# Self-reported Illicit Drug Use Among Norwegian University and College Students: Association with Age, Gender, and Geography

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/self-reported-illicit-drug-use-norwegian-students-age-gender-geography/
> **Published:** 2021-11-09T15:43:45-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:52-04:00
> **Clinical Summary:** Explore self-reported illicit drug use among Norwegian university students and its association with age, gender, and geography in this detailed study overview.

---

In many Western countries, illicit drug use has been purportedly prevalent among students in higher education, even more so than in the general population. A recent study on the self-reported drug use of Norwegian university and college students has confirmed this phenomena and highlighted the need to address this issue.

The study analyzed data from the 2010, 2014, and 2018 installments of the SHoT study (Students’ Health and Well-being Study), a nationwide cross-sectional survey for higher education in Norway that included Norwegian full-time students aged 18–35. Several valuable insights emerged: First, the proportion of students reporting having ever tried illicit drugs increased drastically from 2014 to 2018, for both males (30.8 vs. 36.7%) and females (17.5 vs. 24.0%), while only minimal changes occurred between 2010 and 2014. Second, the most commonly used illicit drugs during 2018 were cannabis (15.2%), followed by MDMA (4.0%), cocaine (3.0%), and LSD/psilocybin (2.1%). For most of these substances, consumption frequency followed an inverted U-shaped pattern with peaked usage in the age span from 23 to 28 years of age while for some others, consumption frequency showed a linear increase with age. In addition, males reported higher illicit drug use compared with females for all drugs. Finally, proportions of illicit drug use varied across geographical areas within the country, with the highest use being reported in the Oslo area (the largest city and capital of Norway).

[More access here](https://cedclinic.com/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Cannabis use, subsequent other illicit drug use and drug use disorders: A 16- year follow-up study among Swedish adults](https://cedclinic.com/cannabis-use-other-illicit-drugs-16-year-study/)

This study explores the long-term relationship between [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and subsequent illicit drug use and disorders in Swedish adults, providing valuable context for student drug use trends.

[Read More](https://cedclinic.com/cannabis-use-other-illicit-drugs-16-year-study/)

[Biobio Sentinel: Two years of illicit drug surveillance in South-Central Chile.](https://cedclinic.com/wastewater-cannabis-surveillance-population-drug-trends-chile/)

An analysis of illicit drug trends through wastewater surveillance in Chile, offering insights into population-level drug use monitoring methods.

[Explore Study](https://cedclinic.com/wastewater-cannabis-surveillance-population-drug-trends-chile/)

[Study: Teen Cannabis Use Linked to Double Psychosis Risk](https://cedclinic.com/teen-cannabis-use-psychosis-risk-study/)

Research highlighting the [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) risks associated with [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), relevant to understanding student drug use implications.

[Learn More](https://cedclinic.com/teen-cannabis-use-psychosis-risk-study/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Self-reported%20Illicit%20Drug%20Use%20Among%20Norwegian%20University%20and%20College%20Students%3A%20Association%20with%20Age%2C%20Gender%2C%20and%20Geography&url=https%3A%2F%2Fcedclinic.com%2Fself-reported-illicit-drug-use-norwegian-students-age-gender-geography%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fself-reported-illicit-drug-use-norwegian-students-age-gender-geography%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Self-reported%20Illicit%20Drug%20Use%20Among%20Norwegian%20University%20and%20College%20Students%3A%20Association%20with%20Age%2C%20Gender%2C%20and%20Geography%20https%3A%2F%2Fcedclinic.com%2Fself-reported-illicit-drug-use-norwegian-students-age-gender-geography%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
